Simple view
Full metadata view
Authors
Statistics
International external quality assurance of "JAK2 V617F" quantification
JAK2 V617F
external quality assurance
myeloproliferative neoplasms
quantitative PCR
External quality assurance (EQA) programs are vital to ensure high quality and standardized results in molecular diagnostics. It is important that EQA for quantitative analysis takes into account the variation in methodology. Results cannot be expected to be more accurate than limits of the technology used, and it is essential to recognize factors causing substantial outlier results. The present study aimed to identify parameters of specific importance for JAK2 V617F quantification by quantitative PCR, using different starting materials, assays, and technical platforms. Sixteen samples were issued to participating laboratories in two EQA rounds. In the first round, 19 laboratories from 11 European countries analyzing JAK2 V617F as part of their routine diagnostics returned results from in-house assays. In the second round, 25 laboratories from 17 countries participated. Despite variations in starting material, assay set-up and instrumentation the laboratories were generally well aligned in the EQA program. However, EQA based on a single technology appears to be a valuable tool to achieve standardization of the quantification of JAK2 V617F allelic burden.
cris.lastimport.wos | 2024-04-09T20:08:40Z | |
dc.abstract.en | External quality assurance (EQA) programs are vital to ensure high quality and standardized results in molecular diagnostics. It is important that EQA for quantitative analysis takes into account the variation in methodology. Results cannot be expected to be more accurate than limits of the technology used, and it is essential to recognize factors causing substantial outlier results. The present study aimed to identify parameters of specific importance for JAK2 V617F quantification by quantitative PCR, using different starting materials, assays, and technical platforms. Sixteen samples were issued to participating laboratories in two EQA rounds. In the first round, 19 laboratories from 11 European countries analyzing JAK2 V617F as part of their routine diagnostics returned results from in-house assays. In the second round, 25 laboratories from 17 countries participated. Despite variations in starting material, assay set-up and instrumentation the laboratories were generally well aligned in the EQA program. However, EQA based on a single technology appears to be a valuable tool to achieve standardization of the quantification of JAK2 V617F allelic burden. | pl |
dc.affiliation | Wydział Lekarski | pl |
dc.cm.date | 2020-01-07 | |
dc.cm.id | 94562 | |
dc.contributor.author | Asp, Julia | pl |
dc.contributor.author | Skov, Vibe | pl |
dc.contributor.author | Bellosillo, Beatriz | pl |
dc.contributor.author | Kristensen, Thomas | pl |
dc.contributor.author | Lippert, Eric | pl |
dc.contributor.author | Dicker, Frank | pl |
dc.contributor.author | Schwarz, Jiri | pl |
dc.contributor.author | Wojtaszewska, Marzena | pl |
dc.contributor.author | Akiki, Susanna | pl |
dc.contributor.author | Aggerholm, Anni | pl |
dc.contributor.author | Andersen, Morten Tolstrup | pl |
dc.contributor.author | Girodon, Francois | pl |
dc.contributor.author | Kjaer, Lasse | pl |
dc.contributor.author | Oppliger Leibundgut, Elisabeth | pl |
dc.contributor.author | Pancrazzi, Alessandro | pl |
dc.contributor.author | Vorland, Marta | pl |
dc.contributor.author | Andrikovics, Hajnalka | pl |
dc.contributor.author | Kralovics, Robert | pl |
dc.contributor.author | Cassinat, Bruno | pl |
dc.contributor.author | Coucelo, Margarida | pl |
dc.contributor.author | Eftimov, Aleksandar | pl |
dc.contributor.author | Haslam, Karl | pl |
dc.contributor.author | Kusec, Rajko | pl |
dc.contributor.author | Link-Lenczowska, Dorota | pl |
dc.contributor.author | Lode, Laurence | pl |
dc.contributor.author | Matiakowska, Karolina | pl |
dc.contributor.author | Naguib, Dina | pl |
dc.contributor.author | Navaglia, Filippo | pl |
dc.contributor.author | Novotny, Guy Wayne | pl |
dc.contributor.author | Percy, Melanie J. | pl |
dc.contributor.author | Sudarikov, Andrey | pl |
dc.contributor.author | Hermouet, Sylvie | pl |
dc.contributor.author | Pallisgaard, Niels | pl |
dc.date.accessioned | 2020-01-17T10:09:14Z | |
dc.date.available | 2020-01-17T10:09:14Z | |
dc.date.issued | 2019 | pl |
dc.date.openaccess | 0 | |
dc.description.accesstime | w momencie opublikowania | |
dc.description.number | 5 | pl |
dc.description.physical | 1111-1118 | pl |
dc.description.points | 70 | pl |
dc.description.version | ostateczna wersja wydawcy | |
dc.description.volume | 98 | pl |
dc.identifier.doi | 10.1007/s00277-018-3570-8 | pl |
dc.identifier.eissn | 1432-0584 | pl |
dc.identifier.issn | 0939-5555 | pl |
dc.identifier.project | ROD UJ / OP | pl |
dc.identifier.uri | https://ruj.uj.edu.pl/xmlui/handle/item/146317 | |
dc.language | eng | pl |
dc.language.container | eng | pl |
dc.rights | Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa | * |
dc.rights.licence | CC-BY | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/legalcode.pl | * |
dc.share.type | inne | |
dc.subject.en | JAK2 V617F | pl |
dc.subject.en | external quality assurance | pl |
dc.subject.en | myeloproliferative neoplasms | pl |
dc.subject.en | quantitative PCR | pl |
dc.subtype | Article | pl |
dc.title | International external quality assurance of "JAK2 V617F" quantification | pl |
dc.title.journal | Annals of Hematology | pl |
dc.type | JournalArticle | pl |
dspace.entity.type | Publication |
* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.
Views
14
Views per month
Views per city
Downloads
Open Access